TerrAscend Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: $10.02
50-Day Range
MA: $11.28
52-Week Range
Now: $10.02
Volume116,258 shs
Average Volume535,580 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. The company was incorporated in 2017 and is based in Mississauga, Canada.
TerrAscend logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings Date5/26/2021 (Estimated)
OptionableNot Optionable


Cowen Begins Coverage on TerrAscend (OTCMKTS:TRSSF)
April 15, 2021 |  americanbankingnews.com
TerrAscend: One MSO To Avoid - Seeking Alpha
April 2, 2021 |  seekingalpha.com
See More Headlines


Overall MarketRank

1.74 out of 5 stars

Medical Sector

201st out of 2,025 stocks

Drug Manufacturers - Specialty & Generic Industry

1st out of 61 stocks

Analyst Opinion: 4.5Community Rank: 4.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRSSF News and Ratings via Email

Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

TerrAscend (OTCMKTS:TRSSF) Frequently Asked Questions

Is TerrAscend a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TerrAscend stock.
View analyst ratings for TerrAscend
or view top-rated stocks.

What stocks does MarketBeat like better than TerrAscend?

Wall Street analysts have given TerrAscend a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but TerrAscend wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting TerrAscend?

TerrAscend saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 170,000 shares, an increase of 59.5% from the March 15th total of 106,600 shares. Based on an average trading volume of 739,700 shares, the short-interest ratio is currently 0.2 days.
View TerrAscend's Short Interest

When is TerrAscend's next earnings date?

TerrAscend is scheduled to release its next quarterly earnings announcement on Wednesday, May 26th 2021.
View our earnings forecast for TerrAscend

How has TerrAscend's stock price been impacted by COVID-19?

TerrAscend's stock was trading at $1.8277 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TRSSF shares have increased by 448.2% and is now trading at $10.02.
View which stocks have been most impacted by COVID-19

What price target have analysts set for TRSSF?

7 analysts have issued twelve-month price objectives for TerrAscend's shares. Their forecasts range from $13.50 to $24.00. On average, they expect TerrAscend's stock price to reach $18.54 in the next twelve months. This suggests a possible upside of 85.0% from the stock's current price.
View analysts' price targets for TerrAscend
or view top-rated stocks among Wall Street analysts.

Who are TerrAscend's key executives?

TerrAscend's management team includes the following people:
  • Mr. Jason Garrett Wild R.Ph., Exec. Chairman
  • Mr. Keith Stauffer, Chief Financial Officer
  • Mr. Matthew Chesler C.F.A., CFA, Head of Investor Relations
  • Mr. Jason M. Marks J.D., Chief Legal Officer (Age 45)
  • Ms. Dawn Vanek-Mithra, Director of Marketing
  • Ms. Joanna Halligan, VP of HR
  • Daniel Foley, Sr. VP & Treasurer

Who are some of TerrAscend's key competitors?

What is TerrAscend's stock symbol?

TerrAscend trades on the OTCMKTS under the ticker symbol "TRSSF."

How do I buy shares of TerrAscend?

Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TerrAscend's stock price today?

One share of TRSSF stock can currently be purchased for approximately $10.02.

What is TerrAscend's official website?

The official website for TerrAscend is www.terrascend.com.

How can I contact TerrAscend?

The company can be reached via phone at 855-837-7295.

This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.